Abstract
The intent of this study was to characterize the effect OTK18 upregulation in monocytic cells had on neuronal survival. The human monocytic cell line, U937, was differentiated into macrophages or left as an undifferentiated monocyte. These cells were transfected with a plasmid containing the enhanced green fluorescent protein and OTK18 (pEGFP-OTK18) or an empty control vector (pEGFP-N3). The supernatants from the transfected U937 cells were used to culture rat neuronal cells (PC12). A live/dead assay was performed to determine the effect of culturing on cell survival. The protein levels of the neurotoxin, tumor necrosis factor alpha (TNF-α), and the neurotrophin, neurotrophin three (NT3), were determined by enzyme linked immunosorbent assay. The results of the live/dead assay showed differential cell survival between conditions with pEGFP-OTK18 when compared to the control empty vector. Quantitative real-time polymerase chain reaction assays demonstrated that OTK18 had an increased expression level when compared to the control. Lastly, NT3 protein levels were upregulated in treated cells with increased OTK18 expression, suggesting that OTK18 may play a role in neurotrophin production and consequently support neuronal survival.
Similar content being viewed by others
References
Aisen P. Inflammation and Alzheimer’s disease: mechanisms and therapeutic strategies. Gerontology 43: 143–149; 1997.
Akira S.; Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol. Rev. 127: 25–50; 1992.
Akiyama H. Inflammatory response in Alzheimer’s disease. Tohoku J. Exp. Med. 174: 295–303; 1994.
Anderson E.; Zink W.; Xiong H.; Gendelman H. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J. Acquir. Immune Defic. Syndr. 31: S43; 2002.
Arvin B.; Neville L.; Barone F.; Feuerstein G. The role of inflammation and cytokines in brain injury. Neurosci. Biobehav. Rev. 20: 445–452; 1996.
Bhuvaneswari R.; Gan Y.; Lucky S.; Chin W.; Ali S.; Soos K.; Olivo M. Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy. Mol. Cancer 7: 56; 2008. doi:10.1186/1476-4598-7-56.
Carlson K.; Leisman G.; Limoges J.; Pohlman G.; Horiba M.; Buescher J.; Gendelman H.; Ikezu T. Molecular characterization of a putative antiretroviral transcriptional factor, OTK18. J. Immunol. 172: 381–391; 2004b.
Carlson K.; Limoges J.; Pohlman G.; Poluektova L.; Langford D.; Masliah E.; Ikezu T.; Gendelman H. OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis. J. Neuroimmunol. 150: 186–198; 2004a.
Chakrabarti R.; Kundu S.; Kumar S.; Chakrabarti R. Vitamin A as an enzyme that catalyzes the reduction of MTT to formazan by vitamin C. J. Cell. Biochem. 80: 133–138; 2000.
Chen S.; Fredrickson K.; Brunden K. Neuroglial-mediated immunoinflammatory responses in Alzheimer’s disease: complement activation and therapeutic approaches. Neurobiol. Aging 17: 781–787; 1996.
Gabuzda D.; Ho D.; de la Mote S.; Hirsch M.; Rota T.; Sobel R. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Neurology 20: 289–295; 1986.
Garrelds I. M.; vanHal P. T. W.; Haakmat R. C.; Hoogsteden H. C.; Saxena P. R.; Zijlstra F. J. Time dependent production of cytokines and eicosanoids by human monocytic leukaemia U937 cells; effects of glucocorticosteroids. Mediat. Inflamm. 8: 229–235; 1999.
Gendelman H.; Grant I.; Everall I.; Lipton S. The neurology of AIDS. Chapman and Hall, New York; 1998a.
Gendelman H.; Orenstein M.; Martin M.; Ferrua C.; Mitra R.; Phipps T.; Wahl L.; Lane H.; Fauci A.; Burke D. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor1-treated monocytes. J. Exp. Med. 167: 1428–41; 1988.
Gendelman H.; Zheng J.; Coulter C.; Ghorpade A.; Che M.; Thylin M.; Rubocki R.; Persidsky T.; Hahn F.; Reinhard Jr J.; Swindells S. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J. Infect. Dis. 178: 1000–7; 1998b.
Hanna-Mitchell A.; O’Leary D.; Mobarak M.; Ramer M.; McMahon S.; Preistly J.; Kozlova E.; Aldskogius H.; Dockery P.; Fraher J. The impact of neurotrophin-3 on the dorsal root transitional zone following injury. Spinal Cord 46: 804–810; 2008 (PMID: 18542093).
Hu J.; Ferreira A.; VanEldik L. S100 β induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69: 2294–2301; 1997.
Huang Z. L.; Failla M. L. Copper deficiency suppresses effector activities of differentiated U937 cells. J. Nutr. 130: 1536–1542; 2000.
Jiang Z.; Piggee C.; Heyes M. P.; Murphy C.; Quearry B.; Bauer M.; Zheng J.; Gendelman H. E.; Markey S. P. Glutamate is a medicator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J. Neuroimmunol. 117: 97–107; 2001.
Keiner S.; Wurm F.; Kunze A.; Witte O.; Redecker C. Rehabilitative therapies differentially alter proliferation and survival of glial cell populations in the perilesional zone of cortical infarcts. Glia 56: 516–527; 2008.
Kieburtz K.; Schiffer R. Neurologic manifestations of human immunodeficiency virus infections. Neurol. Clin. 7: 447–468; 1989.
Kruttgen A.; Moller J.; Heymach J.; Shooter E. Neurotrophin induce release of neurotrophins by the regulated secretory pathway. Proc. Natl. Acad. Sci. 95: 9614–9619; 1998.
Larson, S. L.; Gilling, C. E.; Carlson, K. A. A proposed mechanism for OTK18 regulation of TNF-α in response to neurotoxic insult. SJI: J. Biol. Biol. Syst. Bioinform. 2(1): 1–8; 2008.
Liu L.; Persson J.; Svensson M.; Aldskogius H. Glial cell responses, complement, and clustering in the central nervous system following dorsal root transection. Glia 23: 221–38; 1998.
McGeer P.; McGeer E. Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Dis. Assoc. Disord. 12: 51–56; 1998.
Meng X.; Yang J.; Chen G.; Zhang L.; Wang L.; Li J.; Wang J.; Wu C. RV09, a novel resveratrol analogue, inhibits NO and TNF-alpha production by LPS-activated microglia. Int. Immunopharmacol. 8: 1074–1082; 2008.
Navia B.; Jordan B.; Price R. The AIDS dementia complex: I. Clinical features. Ann. Neurol. 19: 517–524; 1986.
Novak R.; Phillips A. Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis. Cancer Gene. Ther. 15: 713–722; 2008 (PMID: 18551146).
Ohkawara T.; Nishihira J.; Nagashima R.; Takeda H.; Asaka M. Polaprezinc protects human colon cells from oxidative injury induced by hydrogen peroxide: relevant to cytoprotective heat shock proteins. World J. Gastroenterol. 12: 6178–6181; 2006.
Picone R.; Kajtaniak E. L.; Nielsen L. S.; Behrendt N.; Mastronicola M. R.; Cubellis M. V.; Stoppelli M. P.; Pedersen S.; Dano K.; Blasi F. Regulation of urokinase receptors in monocyte-like U937 cells by phorbol ester phorbol myristate acetate. J. Cell Biochem. 108: 693–702; 1989.
Price R.; Brew B. Management of the neurologic complications of HIV infection and AIDS. Infect. Dis. Clin. North Am. 2: 359–372; 1988.
Python F.; Goebel C.; Aeby Assessment of the U937 cell line for the detection of contact allergens. Toxic Appl. Pharm. 220: 113–124; 2007.
Rost B.; Hanf G.; Ohnemus U.; Otto-Knapp R.; Groneberg D. A.; Kunkel G.; Noga O. Monocytes of allergics and non-allergics produce, store and release the neurotophins NGF, BDNF and NT-3. Regul. Pept. 124: 19–25; 2005.
Shibata A.; Zelivyanskaya M.; Limoges J.; Carlson K. A.; Gorantla S.; Branecki C.; Bishu S.; Xiong H.; Gendelman H. E. Peripheral nerve induces macrophage neurotrophic activities: regulation of neuronal process outgrowth, intracellular signaling and synaptic function. J. Neuroimmunol. 142: 112–129; 2003.
Talley A. K.; Dewhurst S.; Perry S. W.; Dollard S. C.; Gummuluru S.; Fine S. M.; New D.; Epstein L. G.; Gendelman H. E.; Gelbard H. A. Tumor necrosis factor alpha-induced apoptosis ;in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15: 2359–2366; 1995.
Tian C.; Erdmann N.; Zhao J.; Cao Z.; Peng H.; Zheng J. HIV-infected macrophages mediate neuronal apoptosis through mitochondrial glutaminase. J. Neurochem. 105: 994–1005; 2008.
Tominaga H.; Ishiyama M.; Ohseto F.; Sasamoto K.; Hamamoto T.; Suzuki K.; Watanabe M. A water-soluble salt useful for colorimetric cell viability assay. Anal. Commun. 36: 47–50; 1998.
Tran T.; McCoy M.; Sporn M.; Tansey M. The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides domaminergic neuroprotection. J. Neuroinflamm. 5: 14; 2008. doi:10.1186/1742-2094-5-14.
Uttamchandani R.; Daikos G.; Reyes R.; Fischl M.; Dickinson G.; Yamaguchi E.; Kramer M. Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin. Infect. Dis. 18: 348–353; 1994.
Wiederholt M. D.; Anderson K. M.; Harris J. E. Labeling of lipids and phospholipids with [3H]arachidonic acid and the biosynthesis of eicosanoids in U937 cells differentiated by phorbol ester. Biochem. Biophys. Acta 959: 296–304; 1988.
Wiley C.; Schrier R.; Nelson S.; Lampert P.; Oldstone M. Cellular localization of human immunodeficiency virus infection within the brains of acquired immunodeficiency syndrome patients. Proc. Natl. Acad. Sci. 83: 7089–7093; 1986.
Wu J.; Qi D.; Wei K.; Chen X.; Wang A.; Liu W.; Xue Q.; Qiao L. 1-[(3-carboxy-1-oxyoprogy1)amino]-2-deoxy-d-glucose induces apoptosis in Hep G2 cells. Exp. Oncol. 27: 52–55; 2005.
Xiao B.; Link H. Immune regulation within the central nervous system. J. Neurol. Sci. 157: 1–12; 1998.
Zatelli M. C.; Piccin D.; Vignali C.; Tagliati F.; Ambrosio M. R.; Bondanelli M.; Cimino V.; Bianchi A.; Schmid H. A.; Scanarini M.; Pontecorvi A.; DeMarinis L.; Maira G.; Uberti E. C. Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. Endocr. Relat. Cancer. 14: 91–102; 2007.
Zhao J.; Lopez A. L.; Erichsen D.; Herek S.; Cotter R. L.; Curthoys N. P.; Zheng J. Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: linkage to HIV-1 associated dementia. J. Neurochem. 88: 169–180; 2004.
Zheng J.; Gendelman H. The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr. Opin. Neurol. 10: 319–25; 1997.
Acknowledgments
The authors thank Stephanie Larson for initial technical assistance. This research was supported by NIH grant no. 1 P20 RR16469 from the INBRE Program of the National Center for Research Resources, the UNK Research Services Council Undergraduate Student Research grant, UNK Office of Sponsored Programs (Summer Student Research Program), the UNK College of Natural and Social Sciences, the UNK Department of Graduate Studies and Research, and the UNK Biology Department.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: J. Denry Sato
Rights and permissions
About this article
Cite this article
Gilling, C.E., Carlson, K.A. The effect of OTK18 upregulation in U937 cells on neuronal survival. In Vitro Cell.Dev.Biol.-Animal 45, 243–251 (2009). https://doi.org/10.1007/s11626-009-9175-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-009-9175-8